ELEVATED AMBULATORY PULSE PRESSURE IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S366
Author(s):  
R. C. Hermida ◽  
C. Calvo ◽  
D. E. Ayala ◽  
M. J. Dominguez ◽  
M. Covelo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pulse Pressure ◽  
Hypertensive Patients ◽  
Ambulatory Pulse Pressure

IMPACT OF ANTIHYPERTENSIVE AGENTS ON CLINIC AND AMBULATORY PULSE PRESSURE IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S124-S125
Author(s):  
I. V. Kotovskaia ◽  
L. A. Lobankova ◽  
Z. D. Kobalava ◽  
V. S. Moiseev
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pulse Pressure ◽  
Antihypertensive Agents ◽  
Hypertensive Patients ◽  
Ambulatory Pulse Pressure

M.530 Elevated ambulatory pulse pressure in patients with type 2 diabetes mellitus

2004 ◽  
Vol 5 (1) ◽  
pp. 122-123
Author(s):  
R. Hermida ◽  
C. Calvo ◽  
D. Ayala ◽  
M. Dominguez ◽  
M. Covelo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pulse Pressure ◽  
Ambulatory Pulse Pressure

scholarly journals Ambulatory Pulse Pressure and Progression of Urinary Albumin Excretion in Older Patients With Type 2 Diabetes Mellitus

Hypertension ◽  
2006 ◽  
Vol 48 (2) ◽  
pp. 301-308 ◽  
Author(s):  
Walter Palmas ◽  
Andrew Moran ◽  
Thomas Pickering ◽  
Joseph P. Eimicke ◽  
Jeanne Teresi ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pulse Pressure ◽  
Older Patients ◽  
Urinary Albumin Excretion ◽  
Urinary Albumin ◽  
Albumin Excretion ◽  
Ambulatory Pulse Pressure

scholarly journals Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure

2012 ◽  
Vol 11 (1) ◽  
pp. 118 ◽  
Author(s):  
Masaya Sakamoto ◽  
Hirofumi Suzuki ◽  
Takeshi Hayashi ◽  
Hiroyuki Iuchi ◽  
Tsuyoshi Isaka ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pulse Pressure ◽  
Hypertensive Patients ◽  
Inflammatory Parameters

Insulin-like growth factor-1 blood levels and carotid artery remodeling in hypertensive patients with type 2 diabetes mellitus

2021 ◽  
Vol 331 ◽  
pp. e172
Author(s):  
L.A. Rieznik ◽  
S.M. Koval ◽  
T. Starchenko ◽  
M.Y. Penkova ◽  
O.V. Mysnychenko
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Growth Factor ◽  
Carotid Artery ◽  
Blood Levels ◽  
Insulin Like Growth Factor ◽  
Hypertensive Patients ◽  
Artery Remodeling

Left Ventricular Geometry and Function in Normotensive and Hypertensive Patients with Type 2 Diabetes Mellitus without Overt Cardiac Symptoms

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
GA Amusa ◽  
SU Uguru ◽  
BI Awokola
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Left Ventricular ◽  
Left Ventricular Geometry ◽  
Hypertensive Patients ◽  
Lv Dysfunction ◽  
Cardiac Symptoms ◽  
And Function

Cardiovascular disease (CVD) is a common cause of morbidity/mortality in patients with type 2 diabetes mellitus (T2DM). Echocardiography can detect changes in cardiac geometry/function before overt CVD symptoms. This study aimed to evaluate left ventricular (LV) geometry and function in normotensive/hypertensive patients with T2DM without overt cardiac symptoms. A cross-sectional study in which fifty normotensives and fifty hypertensive adults with DM without overt cardiac symptoms were enrolled from the cardiology/diabetes clinics of Jos University Teaching Hospital (JUTH) in a simple random manner. Relevant history, physical examination and biochemical investigations were performed. 12-lead electrocardiography and echocardiograph assessment of LV geometry and function were also performed. Data was analyzed using Epi-info 7 statistical software; p value < 0.05 was considered significant. There were 27 females and 29 females in both groups. The prevalence of abnormal LV geometry was 36.0%, 95% CI 33.2-38.8% and 58.0%, 95% CI 55.2-60.8% in the normotensive and hypertensive groups respectively, P=0.028. Similarly, the prevalence of LV dysfunction was 38.0%, 95%CI 35.2-40.8% and 62.0%, 95%CI 59.2-64.8% respectively, P=0.017. The independent predictors of LV dysfunction were found to be duration of diabetes (OR 7.74, 95%CI 4.46-10.46), duration of hypertension ≥5years (OR 4.15, 95%CI 4.01-9.27), smoking (OR 4.34, 95%CI 1.32-6.23), body mass index ≥25 (OR 5.53, 95%CI 1.38-2.09) and glycosylated haemoglobin ≥7 (OR 7.11, 95%CI 2.15-0.81).  There is high prevalence of LV dysfunction/abnormal LV geometry in T2DM patients without overt cardiac symptoms; co-morbid hypertension worsens these abnormalities. Early and periodic echocardiography is recommended with appropriate intervention in these patients.

Sign in / Sign up

Export Citation Format

Share Document